Kathuria Medical Agencies Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 28-06-2024
- Paid Up Capital ₹ 3.33 M
as on 28-06-2024
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.60 M
as on 28-06-2024
- Satisfied Charges ₹ 6.90 M
as on 28-06-2024
- Revenue 25.22%
(FY 2022)
- Profit -48.15%
(FY 2022)
- Ebitda -34.71%
(FY 2022)
- Net Worth 2.10%
(FY 2022)
- Total Assets -1.14%
(FY 2022)
About Kathuria Medical Agencies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.33 M.
The company currently has active open charges totaling ₹3.60 M. The company has closed loans amounting to ₹6.90 M, as per Ministry of Corporate Affairs (MCA) records.
Amarjeet Kathuria and Paramjit Kathuria serve as directors at the Company.
- CIN/LLPIN
U51397PB1996PTC017707
- Company No.
017707
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 1996
- Date of AGM
19 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationPunjab, Punjab
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kathuria Medical Agencies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amarjeet Kathuria  | Director | 30-Sep-1998 | Current |
| Paramjit Kathuria | Director | 08-Feb-1996 | Current |
Financial Performance of Kathuria Medical Agencies.
Kathuria Medical Agencies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.22% increase. The company also saw a substantial fall in profitability, with a 48.15% decrease in profit. The company's net worth moved up by a moderate rise of 2.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kathuria Medical Agencies?
In 2020, Kathuria Medical Agencies had a promoter holding of 87.01% and a public holding of 12.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Punjab Ltd Creation Date: 20 Nov 1997 | ₹1.00 M | Open |
Bank Of Punjab Ltd Creation Date: 20 Nov 1997 | ₹1.00 M | Open |
Bank Of Punjab Ltd Creation Date: 20 Nov 1987 | ₹1.60 M | Open |
How Many Employees Work at Kathuria Medical Agencies?
Unlock and access historical data on people associated with Kathuria Medical Agencies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kathuria Medical Agencies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kathuria Medical Agencies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
